Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis
- PMID: 28542510
- PMCID: PMC5436869
- DOI: 10.1371/journal.pone.0177980
Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis
Abstract
Apolipoproteins are associated with survival among patients on hemodialysis (HD), but these associations might be influenced by dysfunctional (oxidized) high-density lipoprotein (HDL). We assessed associations among apolipoproteins and oxidized HDL, mortality and cardiovascular disease (CVD) events in patients on HD. This prospective observational study examined 412 patients on prevalent HD. Blood samples were obtained before dialysis at baseline to measure lipids, apolipoproteins, oxidized LDL, oxidized HDL, high-sensitivity C-reactive protein (hs-CRP) and interleukin (IL)-6 at baseline, and HDL-C and hs-CRP were measured 12 months later. Patients were then prospectively followed-up (mean, 40 months) and all-cause mortality and composite CVD events were analyzed. Associations between variables at baseline and clinical outcome were assessed by Cox proportional hazards modeling (n = 412) and Cox hazards modeling with a time-varying covariate with HDL-C and hs-CRP (n = 369). Quartiles of apolipoproteins and oxidized HDL were not associated with all-cause mortality. However, Cox proportional hazards models with quartiles of each variable adjusted for confounders and hs-CRP or IL-6 identified apolipoprotein (apo)B-to-apoA-I ratio (apoB/apoA-I) and oxidized HDL, but not apoA-I or apoA-II, as independent risk factors for composite CVD events. These associations were confirmed by Cox proportional hazards modeling with time-varying covariates for hs-CRP. ApoB/apoA-I was independently associated with composite CVD events in 1-standard deviation (SD) increase-of-variables models adjusted for the confounders, oxidized HDL and hs-CRP. However, these associations disappeared from the model adjusted with IL-6 instead of hs-CRP, and oxidized HDL and IL-6 were independently associated with composite CVD events. Findings resembled those from Cox proportional hazards modeling using time-varying covariates with HDL-C adjusted with IL-6. In conclusion, both oxidized HDL and apoB/apoA-I might be associated with CVD events in patients on prevalent HD, while associations of apoB/apoA-I with CVD events differed between models of apoB/apoA-I quartiles and 1-SD increases, and were influenced by IL-6.
Conflict of interest statement
Similar articles
-
Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.Atherosclerosis. 2012 Feb;220(2):493-501. doi: 10.1016/j.atherosclerosis.2011.10.038. Epub 2011 Nov 3. Atherosclerosis. 2012. PMID: 22119537
-
Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.Nephron Clin Pract. 2003;95(4):c128-35. doi: 10.1159/000074838. Nephron Clin Pract. 2003. PMID: 14694274
-
Truncal Adiposity Influences High-Density Lipoprotein Cholesterol Levels and Cardiovascular Events in Hemodialysis Patients.J Ren Nutr. 2019 May;29(3):235-242. doi: 10.1053/j.jrn.2018.08.011. Epub 2018 Oct 12. J Ren Nutr. 2019. PMID: 30322786
-
Modified risk associations of lipoproteins and apolipoproteins by chronic low-grade inflammation.Expert Rev Cardiovasc Ther. 2018 Jan;16(1):39-48. doi: 10.1080/14779072.2018.1417839. Epub 2017 Dec 20. Expert Rev Cardiovasc Ther. 2018. PMID: 29241386 Review.
-
In vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease.Clin Exp Nephrol. 2014 Apr;18(2):261-4. doi: 10.1007/s10157-013-0881-x. Epub 2013 Oct 16. Clin Exp Nephrol. 2014. PMID: 24129559 Review.
Cited by
-
Cardiovascular risk factors in children on dialysis: an update.Pediatr Nephrol. 2020 Jan;35(1):41-57. doi: 10.1007/s00467-018-4125-x. Epub 2018 Oct 31. Pediatr Nephrol. 2020. PMID: 30382333 Review.
-
The miR-23-27-24 cluster: an emerging target in NAFLD pathogenesis.Acta Pharmacol Sin. 2022 May;43(5):1167-1179. doi: 10.1038/s41401-021-00819-w. Epub 2021 Dec 10. Acta Pharmacol Sin. 2022. PMID: 34893685 Free PMC article. Review.
-
Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.Lipids Health Dis. 2018 Apr 4;17(1):71. doi: 10.1186/s12944-018-0718-4. Lipids Health Dis. 2018. PMID: 29618370 Free PMC article.
-
Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation.Pediatr Nephrol. 2021 Aug;36(8):2537-2544. doi: 10.1007/s00467-021-05102-y. Epub 2021 Jun 18. Pediatr Nephrol. 2021. PMID: 34143301 Review.
-
High-density lipoprotein regulates angiogenesis by affecting autophagy via miRNA-181a-5p.Sci China Life Sci. 2024 Feb;67(2):286-300. doi: 10.1007/s11427-022-2381-7. Epub 2023 Oct 25. Sci China Life Sci. 2024. PMID: 37897614
References
-
- Umemoto T, Han CY, Mitra P, Averill MM, Tang C, Goodspeed L, et al. Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1. Circ Res. 2013;112: 1345–1354 10.1161/CIRCRESAHA.111.300581 - DOI - PMC - PubMed
-
- Johnson WJ, Kilsdonk EP, van Tol A, Phillips MC, Rothblat GH. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII. J Lipid Res. 1991;32: 1993–2000. - PubMed
-
- Huang Y, von Eckardstein A, Wu S, Assmann G. Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma. Arterioscler Thromb Vasc Biol. 1995;15: 1412–1418. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous